Autologous Induced Pluripotent Stem Cells（HeartWorks）

N/A

Report date: 2023/01/12 16:09:08

Base Information

Drug NameAutologous Induced Pluripotent Stem Cells（HeartWorks）
Drug Alias NameiPSC-CL（HeartWorks）Autologous Induced Pluripotent Stem Cells of Cardiac Lineage（HeartWorks）
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHeart FailureUniventricular HeartHeart Defects, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHeartWorks Inc
Inactive CompaniesN/A
Active IndicationsHeart FailureUniventricular HeartHeart Defects, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A